Related Experiment Video
Updated: Jun 21, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Hypercalcemia in acute lymphoblastic leukemia: an overview.
Amita Trehan1, Timothy Cheetham, Simon Bailey
1Advanced Paediatric Centre, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Journal of Pediatric Hematology/Oncology
|August 4, 2009
Summary
Hypercalcemia, a serious metabolic emergency, is an uncommon feature of childhood leukemia. This study explores its associations and impact on patient outcomes.
Area of Science:
- Pediatric Oncology
- Biochemistry
Background:
- Hypercalcemia presents with nonspecific symptoms but can be a life-threatening metabolic emergency.
- It is an uncommon but recognized biochemical feature in childhood malignancies, including acute leukemia.
- The pathogenesis and long-term implications of hypercalcemia in pediatric cancer are not fully understood.
Observation:
- Children with acute lymphoblastic leukemia and hypercalcemia are often older and may lack peripheral blood blasts.
- Chromosomal translocation 17;19 appears more frequent in hypercalcemic pediatric leukemia patients.
- Less common immunophenotypes, such as CD19 negativity and CD10 positivity, are observed in hypercalcemic cases.
Findings:
- Hypercalcemia in pediatric acute lymphoblastic leukemia is associated with older age and specific chromosomal translocations.
- While linked to certain features, hypercalcemia itself may not be a direct prognostic indicator.
- Specific immunophenotypic profiles can be associated with hypercalcemia in this population.
Implications:
- Understanding hypercalcemia's role in pediatric hematologic malignancies is crucial for comprehensive patient management.
- Further research into pathogenesis may reveal targeted therapeutic strategies.
- This highlights the importance of recognizing and investigating hypercalcemia in children with cancer for better outcomes.
